Clinical Trials Search Results
Results 1-10 of 466 for your search
Show Search Criteria
Your Search Criteria
Category |
Your Selection |
|---|---|
| Keywords/Phrases: | head and neck |
Crizotinib in Treating Patients with Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 1381 locations
Age: 18 years and over
Gender: Male or Female
Location: 1381 locations
Weight Loss Interventions in Treating Overweight and Obese Women with a Higher Risk for Breast Cancer Recurrence
Status: Active
Age: 18 years and over
Gender: Female
Location: 1345 locations
Age: 18 years and over
Gender: Female
Location: 1345 locations
Aspirin in Preventing Recurrence of Cancer in Patients with Node Positive or High Risk Node Negative, HER2 Negative Breast Cancer after Chemotherapy, Surgery, and / or Radiation Therapy
Status: Active
Age: 18 to 69 years
Gender: Male or Female
Location: 1275 locations
Age: 18 to 69 years
Gender: Male or Female
Location: 1275 locations
Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 1190 locations
Age: 18 years and over
Gender: Male or Female
Location: 1190 locations
Erlotinib Hydrochloride in Treating Patients with Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 1323 locations
Age: 18 years and over
Gender: Male or Female
Location: 1323 locations
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel with or without Carboplatin in Treating Patients with Triple-Negative Breast Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 1106 locations
Age: 18 years and over
Gender: Male or Female
Location: 1106 locations
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients with Stage III-IV BRAFV600 Melanoma
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 712 locations
Age: 18 years and over
Gender: Male or Female
Location: 712 locations
Pembrolizumab in Treating Patients with Triple-Negative Breast Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 761 locations
Age: 18 years and over
Gender: Male or Female
Location: 761 locations
Standard or Comprehensive Radiation Therapy in Treating Patients with Early-Stage Breast Cancer Previously Treated with Chemotherapy and Surgery
Status: Active
Age: 18 years and over
Gender: Female
Location: 600 locations
Age: 18 years and over
Gender: Female
Location: 600 locations
Testing maintenance immunotherapy versus observation in patients with oropharynx cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 388 locations
Age: 18 years and over
Gender: Male or Female
Location: 388 locations